Skip to main content
×
×
Home

The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis

  • Elise A. Weamer (a1) (a2), James E. Emanuel (a1), Daniel Varon (a1), Sachiko Miyahara (a3), Patricia A. Wilkosz (a1), Oscar L. Lopez (a1) (a2), Steven T. DeKosky (a1) and Robert A. Sweet (a1) (a2) (a4)...
Abstract
ABSTRACT

Background: Psychotic symptoms in Alzheimer disease (AD + P) identify a heritable phenotype associated with greater cognitive impairment. Knowing when the cognitive course of AD + P subjects diverges from that of subjects without psychosis would enhance understanding of how genetic variation results in AD + P and its associated cognitive burden. This study seeks to determine whether the degree of cognitive impairment and cognitive decline in early AD predicts subsequent AD + P onset.

Methods: 361 subjects with possible or probable AD or mild cognitive impairment (MCI) without psychosis were evaluated every 6 months until psychosis onset.

Results: Severity of cognitive dysfunction was a strong predictor of AD + P up to two years prior to psychosis onset. Cognition did not decline more rapidly prior to onset of AD + P.

Conclusions: Individuals who will develop AD + P already demonstrate excess cognitive impairment during the mild stages of disease. Genetic variation and brain pathophysiology may lead to a cognitive risk phenotype which is present prior to dementia onset.

Copyright
Corresponding author
Correspondence should be addressed to: Robert A. Sweet, M.D., Associate Professor of Psychiatry and Neurology, Biomedical Science Tower, Rm W-1645, 3811 O'Hara Street, Pittsburgh, PA 15213–2593, U.S.A. Phone + 1 412 383 8548; Fax + 1 412 624 9910. Email: sweetra@upmc.edu.
References
Hide All
Bacanu S. A., Devlin B., Chowdari K. V., DeKosky S. T., Nimgaonkar V. L. and Sweet R. A. (2002). Linkage analysis of Alzheimer disease with psychosis. Neurology, 59, 118120.
Ballard C. G., O'Brien J. T., Coope B. and Wilcock G. (1997). Psychotic symptoms in dementia and the rate of cognitive decline. Journal of the American Geriatrics Society, 45, 10311032.
Becker J. T., Boller F., Saxton J. and McGonigle-Gibson K. L. (1987). Normal rates of forgetting of verbal and non-verbal material in Alzheimer's disease. Cortex, 23, 5972.
Becker J. T., Boller F., Lopez O. L., Saxton J. and McGonigle K. L. (1994). The natural history of Alzheimer's disease: description of study cohort and accuracy of diagnosis. Archives of Neurology, 51, 585594.
Benton A. L. (1968). Differential behavioral effects in frontal lobe disease. Neuropsychologia, 6, 5360.
Benton A. L., Hamsher K., Varney N. R. and Spreen O. (1983). Contribution to Neuropsychological Assessment: A Clinical Manual. New York: Oxford University Press.
Borkowski J. G., Benton A. L. and Spreen O. (1967). Word fluency and brain damage. Neuropsychologia, 5, 135140.
Davies C. A., Mann D. M., Sumpter P. Q. and Yates P. O. (1987). A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. Journal of the Neurological Sciences, 78, 151164.
DeKosky S. T. and Scheff S. W. (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Annals of Neurology, 27, 457464.
Drevets W. C. and Rubin E. H. (1989). Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biological Psychiatry, 25, 3948.
Folstein M. F., Folstein S. E. and McHugh P. R. (1975). “Mini mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Glantz L. A. and Lewis D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry, 57, 6573.
Guenette S. Y. and Tanzi R. E. (1999). Progress toward valid transgenic mouse models for Alzheimer's disease. Neurobiology of Aging, 20, 201211.
Hollingworth P. et al. (2007). Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 144B, 841848.
Hsia A. Y. et al. (1999). Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proceedings of the National Academy of Sciences U.S.A, 96, 32283233.
Jeste D. V., Wragg R. E., Salmon D. P., Harris M. J. and Thal L. J. (1992). Cognitive deficits of patients with Alzheimer's disease with and without delusions. American Journal of Psychiatry, 149, 184189.
Kaplan E. F., Goodglass H. and Weintraub S. (1983). The Boston Naming Test. Philadelphia: Lea & Febiger.
Levy M. L., Cummings J., Fairbanks L. A., Bravi D., Calvani M. and Carta A. (1996). Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. American Journal of Psychiatry, 153, 14381443.
Lopez O. L., Kamboh M. I., Becker J. T., Kaufer D. I. and DeKosky S. T. (1997). The apolipoprotein E ɛ4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology, 49, 794797.
Lopez O. L., Wisniewski S. R., Becker J. T., Boller F. and DeKosky S. T. (1999). Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Archives of Neurology, 56, 12661272.
Lopez O. L. et al. (2000)a. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades. I. Neurology, 55, 18541862.
Lopez O. L. et al. (2000)b. Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades. II. Neurology, 55, 18631869.
Lopez O. L. et al. (2003). Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Archives of Neurology, 60, 13851389.
Masliah E. et al. (2001). Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology, 56, 127129.
McKhann G., Drachman D., Folstein M., Katzman R., Price D. and Stadlan E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939944.
Niendam T. A. et al. (2003). A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. American Journal of Psychiatry, 160, 20602062.
Paulsen J. S. et al. (2000)a. Neurobehaviors and psychotic symptoms in Alzheimer's disease. Journal of the International Neuropsychological Society, 6, 815820.
Paulsen J. S. et al. (2000)b. Incidence of and risk factors for hallucinations and delusions in patients with probable Alzheimer's disease. Neurology, 54, 19651971.
Reitan R. M. and Wolfson D. (1993). The Halstead-Reitan Neuropsychological Test Battery. Tuson: Neuropsychology Press.
Rockwell E., Jackson E., Vilke G. and Jeste D. V. (1994). A study of delusions in a large cohort of Alzheimer's disease patients. American Journal of Geriatric Psychiatry, 2, 157164.
Rosen W. G., Mohs R. C. and Davis K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 13561364.
Saxton J. et al. (2004). Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology, 63, 23412347.
Scarmeas N. et al. (2005). Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology, 62, 16011608.
Scheff S. W. and Price D. A. (2003). Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiology of Aging, 24, 10291046.
Snitz B. E., Macdonald A. W. III and Carter C. S. (2006). Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophrenia Bulletin, 32, 179194.
Snowdon D. A., Kemper S. J., Mortimer J. A., Greiner L. H., Wekstein D. R. and Markesbery W. R. (1996). Linguistic ability in early life and cognitive function and Alzheimer's disease in late life – findings from the Nun Study. JAMA, 275, 528532.
Stern Y., Mayeux R., Sano M., Hauser W. A. and Bush T. (1987). Predictors of disease course in patients with probable Alzheimer's disease. Neurology, 37, 16491653.
Sweet R. A., Nimgaonkar V. L., Kamboh M. I., Lopez O. L., Zhang F. and DeKosky S. T. (1998). Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer's disease. Archives of Neurology, 55, 13351340.
Sweet R. A., Nimgaonkar V. L., Devlin B., Lopez O. L. and DeKosky S. T. (2002)a. Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology, 58, 907911.
Sweet R. A. et al. (2002)b. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiology of Aging, 23, 547553.
Sweet R. A. et al. (2005). Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Molecular Psychiatry, 10, 10261036.
Sweet R. A., Bergen S. E., Sun Z., Marcsisin M. J., Sampson A. R. and Lewis D. A. (2007). Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biological Psychiatry, 61, 854864.
Tariot P. N. et al. and Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease (1995). The behavior rating scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease. American Journal of Psychiatry, 152, 13491357.
Wechsler D. (1987). The Wechsler Memory Scale Manual-Revised. New York: The Psychological Corporation.
Whalley L. J., Starr J. M., Athawes R., Hunter D., Pattie A. and Deary I. J. (2000). Childhood mental ability and dementia. Neurology, 55, 14551459.
Wilkosz P. A., Miyahara S., Lopez O. L., DeKosky S. T. and Sweet R. A. (2006). Prediction of psychosis onset in Alzheimer disease: the role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes. American Journal of Geriatric Psychiatry, 14, 352356.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 2
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 108 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st January 2018. This data will be updated every 24 hours.